mevastatin has been researched along with cyclosporine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Avery, VM; Sykes, ML | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| al Rayyes, O; Florén, CH; Wallmark, A | 1 |
| Fónagy, A; Maeda, S; Matsumoto, S; Okano, K; Ozawa, R; Tatsuki, S; Yokoyama, N | 1 |
| Duriez, P; Fruchart, JC; Hazzan, M; Kandoussi, A; Martin, F; Noël, C; Staels, B | 1 |
| Cha, BY; Nagai, K; Teruya, T; Woo, JT; Yonezawa, T | 1 |
2 review(s) available for mevastatin and cyclosporine
| Article | Year |
|---|---|
Approaches to protozoan drug discovery: phenotypic screening.
Topics: Drug Discovery; Humans; Molecular Structure; Neglected Diseases; Phenotype; Plasmodium falciparum; Protozoan Infections; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi | 2013 |
Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival.
Topics: Animals; Apoptosis; Bacteria; Bone Density Conservation Agents; Bone Resorption; Cell Differentiation; Cell Survival; Cyclosporine; Depsipeptides; Fungi; Heterocyclic Compounds, 3-Ring; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Osteoclasts; Prodigiosin; Pyrans; Spiro Compounds; Tacrolimus | 2008 |
6 other study(ies) available for mevastatin and cyclosporine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Topics: Anticholesteremic Agents; Biological Transport, Active; Cyclosporine; Down-Regulation; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lipoproteins, LDL; Lovastatin; Receptors, LDL; Tumor Cells, Cultured; Up-Regulation | 1997 |
Involvement of calcineurin in the signal transduction of PBAN in the silkworm, Bombyx mori (Lepidoptera).
Topics: Animals; Blotting, Western; Bombyx; Calcineurin; Calcineurin Inhibitors; Cell-Free System; Cyclosporine; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Fatty Alcohols; Female; In Vitro Techniques; Insect Proteins; Lovastatin; Neuropeptides; Sex Attractants; Signal Transduction; Tacrolimus | 1999 |
HMG-CoA reductase inhibition and PPAR- alpha activation both inhibit cyclosporin A induced endothelin-1 secretion in cultured endothelial cells.
Topics: Animals; Aorta; Cattle; Cells, Cultured; Clofibric Acid; Cyclosporine; Endothelin-1; Endothelium, Vascular; Fibric Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lovastatin; Mevalonic Acid; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2002 |